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Background: Cognitive impairment is an established feature of schizophrenia and is a strong predictor of eventual
social and functional outcome. Few studies have investigated cognitive impairment in hospital long-stay patients
with schizophrenia. This study evaluates and compares cognitive function among a sample of patients with
schizophrenia in both inpatient and outpatient departments in order to determine the relationship between
cognitive impairment and clinical variables.
A cross-sectional comparative study based on a semi-structured interview investigating 100 inpatients with schizophrenia
recruited from El-Abassia Mental Health Hospital departments compared to 100 patients with schizophrenia selected from
the outpatients’ clinic matched with cases. The assessment tools included SCID-I, the Adult Wechsler Intelligence Scale, the
computerized version of Wisconsin Card Sorting Test (WCST), Mini-Mental State Examination (MMSE), and Positive and
Negative Syndrome Scale (PANSS).
Results: Patients with schizophrenia showed significant deficits on cognitive function with no statistically
significant difference between the inpatient and outpatient groups. Executive function was significantly
correlated with verbal, non-verbal, and total IQ. Executive function was negatively correlated with the positive
and general symptoms of PANSS and not correlated with its negative symptoms. In addition, we did not find
any statistically significant relationship between cognitive functions and the duration of illness.
Conclusion: The study provides evidence that institutionalization is not an influential factor on cognitive
impairment patients with schizophrenia. However, the psychopathological aspects of the disorder are one of
the crucial factors affecting the cognitive function in schizophrenia.
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Inpatient vs. outpatientBackground
Cognitive dysfunction has been viewed as a core feature of
schizophrenia since it was first conceptualized. Kraepelin
used the term “dementia praecox” to describe the func-
tional and intellectual deterioration as key disease features.© The Author(s). 2020 Open Access This article
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Full list of author information is available at the end of the articleRecent evidence suggests that 50–70% of patients with
schizophrenia have neuro-cognitive deficits [1].
Cognitive deficits are reported in high-risk groups
prior to the onset of psychotic illness, and deficits are
broadly evident at the first episode and remain fairly
stable through middle age [2], but there is evidence of
exacerbation of deficits in later life, perhaps due to the
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have been identified in most cognitive domains, basic
sensory and perceptual functions, and higher order cog-
nition, including selective and sustained attention, work-
ing memory, episodic memory, processing speed, and
problem-solving [4]. These deficits predate the onset of
clinical symptoms, represent a decline from previous
level of functioning persist over the disease course, and
are more closely linked to function than are clinical
symptoms of schizophrenia [5, 6].
The association between the severity of cognitive defi-
cits and psychopathologic symptoms is controversial,
and many studies showed a significant but modest asso-
ciation between the severity of cognitive deficits and
negative symptoms, but no association between
cognitive deficits and positive symptoms, such as halluci-
nations and delusions [6]. In addition, prolonged
hospitalization of a patient with schizophrenia was found
to impair the cognitive functions to a great extent than
that due to schizophrenia alone which is evident by lon-
gitudinal follow-up of patients who have been chronic-
ally hospitalized most of their adult lives suggesting
greater than age-expected cognitive decline and conver-
sion to clinical dementia [5].
Taken together, the evidence above suggests that cog-
nitive deficits in schizophrenia represent a dimensional
phenomenon rather than a single complaint. This is also
consistent with recent findings of genetic studies, in
which multiple genes of small effect individually contrib-
ute to illness susceptibility via different pathophysio-
logical processes [7]. Recent evidence suggests that a
variant in dysbindin, which slightly elevates risk for
schizophrenia, is also associated with the severity of
negative symptoms and generalized cognitive deficits [8].
Meanwhile, variants in DISC1 are associated with perse-
cutory delusions and working memory deficits [9].
The current study aimed to examine and compare
cognitive function among a sample of patients with
schizophrenia in both inpatient and outpatient depart-
ments and to determine the relationship between cogni-
tive impairment and clinical variables especially for the
positive and negative symptoms.
Methods
A cross-sectional, comparative study was conducted at El
Abbassia Mental Health hospital among patients diagnosed
with schizophrenia recruited from the inpatient wards and
outpatient clinic. The patient sampling started from January
2012 till October 2012. The researchers included patients be-
tween 30 and 60 years old with no gender preference. They
plotted an operational definition for the long-stay hospital
patients: those patients with duration of illness of at least 7
years and has been hospitalized for at least the last 5 years
consecutively. However, patients whose IQ ≤ 70, receivingrecent course (3months) of BST (brain synchronizing ther-
apy), were excluded from the current study. Meanwhile, the
presence of comorbid neurological or other psychiatric disor-
ders as well as any debilitating disease was considered as ex-
clusion criteria. The recruited outpatient group fulfilled the
same inclusion and exclusion criteria except for being hospi-
talized in the last 3months. The authors succeeded in col-
lecting 200 patients (100 from the inpatient ward and 100
from the outpatient clinic).
Patients were first interviewed by a trained psych-
iatrist. The diagnosis of schizophrenia and exclusion of
other psychiatric disorders were performed according to
DSM-IV by using SCID-I [10], and the IQ was estimated
based on the Wechsler intelligence scale for adults [11]
to exclude the mentally subnormal cases. They were
then evaluated regarding the severity and different symp-
toms of schizophrenia by using the Positive and Negative
Syndrome Scale (PANSS) [12, 13]. Furthermore, the
Mini-Mental State Examination (MMSE) was used to
screen patients for cognitive impairment, track changes
in cognitive functioning over time, and often to assess
the effects of therapeutic agents on cognitive function
[14], and Wisconsin Card Sorting Test (WCST) allows
the clinician to assess different “frontal” lobe functions
as strategic planning, priority setting, utilizing environ-
mental feedback to shift cognitive sets, impulsivity con-
trol, and directing behavior toward achieving a goal [15].
Data collection regarding socio-demographics and
clinical profile was obtained by the researcher according
to El Abbassia Hospital admission file. This study has
been approved by the Ethics and Research Committee at
El Abassia mental hospital. Written informed consent
from patients was received prior to data collection.
Statistical analyses
All data were recorded and statistical analysis was done
using the Statistical Package for Social Science (SPSS)
for Windows (version 17). The results were tabulated,
grouped, and statistically analyzed using suitable statis-
tical parameters.
Continuous variables such as age were expressed as mean
± standard deviation, whereas categorical variables such as
gender were presented as frequencies. Pearson’s chi-square
test (χ2) was used to detect whether there is a significant
association between different categorical variables. Further-
more, Spearman’s correlation was used to test the association
between cognitive functions and different clinical variables.
The significance level was set at p < 0.05.
Results
Socio-demographic and clinical characteristics across
inpatient and outpatient groups
Among the entire sample, the male gender represents
nearly 60% of the recruited sample in comparison to
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inpatient group and was 43.24 ± 7.76 years for the out-
patient group with a highly statistically significant differ-
ence (p = 0.000). The majority of the outpatient group
was from urban places 93%, and only 7% of the out-
patient group came from rural places with a highly sig-
nificant statistical difference (p = 0.00) as shown in
Table 1. The educational level varies rather in the outpa-
tients as well as the inpatient group showing that 70% of
the inpatient group reached a higher level of education
in comparison to 46% in the outpatient group with a
highly significant statistical difference (p = 0.001).
All calculations were performed at 95% confidence
limits; the confidence interval is 5%.
Regarding the PANSS, there was no significant statis-
tical difference between both groups (p = 0.7). The nega-
tive subscale had a mean of 19.18 ± 5.39 in the inpatient
group as well as 19.64 ± 5.19 in the outpatient group.
The positive subscale had 15.16 ± 5.21 for the inpatient
group and 15.74 ± 5.22 for the outpatient group. Meanwhile,
the general psychopathology scores were 41.95 ± 12.35 in
the inpatients and 42.58 ± 10.66 in the out patients.
Comparison of neurocognitive function subtests across
inpatient and outpatient groups
As shown in Table 2, there was no statistically signifi-
cant difference regarding the intellectual function (that
was assessed by both WAIS and MMSE) among bothTable 1 Sociodemographic and clinical characteristics across inpatie
Variables Inpatient group (n = 10













Read and write to primary 30 (30%)
Higher than primary education 70 (70%)
PANSS
Positive symptoms 15.6 ± 5.21
Negative symptoms 19.18 ± 5.39
General psychopathology 41.95 ± 12.35
*Independent t testgroups (p > 0.05). Meanwhile, there was no statistically
significant difference between the inpatients and outpa-
tients among the frontal lobe cognitive functions (that
were assessed by WCST) (p > 0.05).
Correlation between the executive function and the
general intellectual abilities
Table 3 showed a significant positive correlation be-
tween the category completed and the total, verbal, and
performance IQ denoting higher overall executive per-
formance with higher total and subtype IQ. However,
the total percentage of errors was inversely correlated to
the total, verbal, and performance IQ indicating lower
concentration abilities with higher intellectual abilities.
Correlation between the executive function and
schizophrenia symptom severity
Table 4 showed a significant inverse correlation between
the category completed and both the positive symptoms
and the general psychopathology scores which implies
the higher overall executive functions with less severe
positive symptoms (p = 0.001, r = − 0.226). In contrast,
the authors found no significant correlation between the
negative symptoms and frontal lobe functions.
Discussion
Cognitive impairment is a crucial factor related to treat-
ment outcome, and neurocognitive deficits appear tont and outpatient groups
0) Outpatient group (n = 100) P value*















15.74 ± 5.22 0.539
19.64 ± 5.19 0.432
42.58 ± 10.66 0.7
Table 2 Comparison of neuro-cognitive function subtests across inpatient and outpatient groups
Variables Inpatient group (n = 100) Outpatient group (n = 100) P value*
Mean ± SD Mean ± SD
WAIS
WAIS—total 89.41 ± 10.46 86.99 ± 10.72 0.108
WAIS—verbal 95.61 ± 13.22 92.33 ± 11.50 0.063
WAIS—performance 87.00 ± 12.34 85.74 ± 13.51 0.492
MMSE 21.05 ± 454 21.85 ± 4.57 0.215
WCST
Category completed 2.21 ± 179 2.75 ± 2.07 0.05
Total errors 67.35 ± 20.12 61.97 ± 23.65 0.085
Preservative errors 21.00 ± 15.74 12.54 ± 0.099 0.0921
Non-preservative errors 46.60 ± 29.67 28.98 ± 1.41 0.160
Time to complete 1st category 20.21 ± 21.39 20.44 ± 0.585 0.559
PANSS
Positive symptoms 15.6 ± 5.21 15.74 ± 5.22 0.539
Negative symptoms 19.18 ± 5.39 19.64 ± 5.19 0.432
General psychopathology 41.95 ± 12.35 42.58 ± 10.66 0.7
WAIS Wechsler Adult Intelligence Scale, MMSE Mini-Mental State Examination, WCST Wisconsin Card Sorting Test, PANSS Positive and Negative Syndrome Scale
*Independent t test
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and also interfere with social function in patients with
schizophrenia [18, 19]. Schizophrenia is considered the
most common chronic variety of psychosis in Egypt and
represents the major bulk of inpatients in our mental
hospitals [20]. The aim of this study was to assess and
compare the cognitive function pattern among a sample
of subjects with schizophrenia in both inpatient and out-
patient departments and to determine the relationship
between cognitive impairment and clinical variables.
In this study, patients with schizophrenia (both in-
patient and outpatient groups) showed an overall cogni-
tive impairment on various neuropsychological tests that
is consistent with many studies that revealed clinical
cognitive impairment in 50–85% of patients with schizo-




Category completed 0.485 0.000
Total errors − 0.461 0.000
Preservative errors 0.101 0.155
Non-preservative errors − 0.396 0.000
Times to complete 1st category 0.179 0.011
WCST Wisconsin Card Sorting Test, IQ intellectual quotient
*Independent t testbrain region or one neuropsychological process and may
reflect both multifocal and diffuse brain diseases sug-
gesting that structural damage, mainly consisting of
white matter micro-ischemic lesions, may be responsible
for the development of cognitive impairment in patients
with schizophrenia [27, 28].
There was no statistically significant difference in the
cognitive functions between the long-stay inpatient and
outpatient groups of patients with schizophrenia. Similar
to our results, Harvey and colleagues [29] concluded that
there is minimal evidence that hospitalization, long or
short, leads to cognitive and functional changes, but ra-
ther that the reason for these hospitalizations may
underlie cognitive and functional declines. At the same
time, Mosiołek, et.al; 2016 [30] found that most cogni-
tive functions show a slight connection to the age andPerformance IQ Total IQ
r P value* r P value*
0.442 0.000 0.596 0.000
− 0.445 0.000 − 0.573 0.000
0.123 0.084 0.125 0.077
− 0.391 0.000 − 0.488 0.000
0.058 0.412 0.130 0.067
Table 4 Correlation between executive functions and schizophrenia symptom severity
Variables Positive symptoms Negative symptoms General psychopathology
r p value r p value r p value
WCST
Category completed − 0.226 0.001 − 0.142 0.000 − 0.223 0.002
Total errors 0.220 0.002 0.122 0.000 0.224 0.001
Preservative errors − 0.186 0.008 − 0.079 0.267 − 0.157 0.027
Non-preservative errors 0.260 0.000 0.133 0.060 0.237 0.001
Times to complete 1st category − 0.043 0.547 − 0.056 0.429 0.025 0.725
Spearman correlation
WCST Wisconsin Card Sorting Test
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(cognitive rigidity) seem to be associated with the differ-
ence between the time when the disease begun and the
number of years since the first hospitalization. The lon-
ger the period of time spent without hospitalization the
greater the cognitive rigidity shown in their study which
could be connected with fixed deficits caused by a long
period when patients were not treated, at least in some
cases. Also, Davidson’s study it 2000 suggested that
cognitive impairment is responsible for long-term
hospitalization, rather than supporting the notion that
cognitive impairment is a secondary result of long-term
institutionalization [31]. In contrast to the current study,
Ojeda in 2007 reviews 30 studies published in patients
with schizophrenia both first and multiple psychotic epi-
sodes. However, the results suggest that significant cog-
nitive symptoms are present at the onset of the disease
and these remain stable in the subsequent period be-
tween 2 and 5 years. Their deterioration increases with
the course of the disease, especially in institutionalized
patients [32]. The difference between these studies may
be related to different clinical criteria in addition to the
evaluation methods used.
Regarding the schizophrenia profiles, the current study
confirmed the impact of positive and general symptoms
of schizophrenia on cognitive functions; this is in agree-
ment with prior reports of significant correlations of
positive symptoms with working memory [33], source
monitoring [34], and auditory distractibility [35] as the
overall trend is for general neuro-cognitive impairment
not to be correlated with positive symptoms. This low
correlation across various patient samples suggests that
positive symptoms are largely not the sole cause of the
cognitive impairment found in patients with schizophre-
nia. On the other hand, it was found that negative symp-
toms had a non-significant correlation with cognitive
functions. In contrast to the current study, Davidson re-
vealed significant correlations between cognitive impair-
ment and negative symptoms, and their magnitude did
not change throughout the entire lifespan. Theseassociations prove the hypothesis that the two symptoms
share a common biological substrate [36].
In line with the current study, the total, verbal, and
performance IQ were positively correlated with the ex-
ecutive function. Previous studies notified that schizo-
phrenia is associated with global intellectual impairment
and deficits in executive functioning, memory, and at-
tention [37], and the performance of patients with
schizophrenia differs from controls by approximately
one to two standard deviation which has a greater im-
pact on cognitive functions and associated with worse
psychosocial functioning [22, 38, 39, 40].
Finally, the authors did not find any evidence for a re-
lationship between the duration of illness and the cogni-
tive deficits among the sample of schizophrenia.
Although some researchers implied that those psychotic
episodes may be neurotoxic, with increasing length of ill-
ness especially without treatments associated with a poor
prognosis, no study has yet yielded direct evidence that
this has occurred. Most studies of cognitive function
evaluation in schizophrenia have revealed that cognitive
deficits are present during the early years of illness and
remain stable throughout the course of the disorder [32,
41] supporting the model of cognitive deficits as primary
domain related to schizophrenia, although there was no
relation found between duration of illness and cognitive
impairment [42].
The current work is one of the scarce Egyptian studies
evaluating the cognitive function among long-stay inpa-
tients with schizophrenia and its relation to clinical vari-
ables. This study design has several strengths and
weaknesses. First, the use of selected cognitive tests to
measure the cognitive functions may prevent a global
understanding of the different cognitive domains. In
addition, the authors cannot rule out the effect that
neuroleptic medications had a direct effect on cognitive
functions even though analyses did not reveal significant
correlations. Further, the small sample size may be a fac-
tor that reduced statistical power, so, potentially
heightens the occurrence of type II errors.
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To conclude, the authors found that long institutionalization
was not the influential cause for cognitive deterioration in
patients with schizophrenia; however, other causes such as
the presence of psychopathology and positive and negative
symptoms are the cornerstone in the level of cognitive deteri-
oration especially the executive functions. Cognitive deficits
in long-stay inpatients with schizophrenia need to come into
focus as regards investigation and treatment, and it is import-
ant to throw the highlights on the preventable factors that
may contribute to its development. This may improve the
outcome and prognosis of those patients to sustain high
work productivity and offer better quality of life.
The results of the current study could not be general-
ized due to several limitations in the study design as the
number of recruited sample which could be increased in
further studies with multicentered selection of cases.
Also, some data are collected from the patient’s files
retrospectively and could be affected by documentation
bias.
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